Correction for “Effectiveness of Subcutaneously Administered Leuprolide Acetate to Achieve Low Nadir Testosterone in Prostate Cancer Patients”

類似資料

• Effectiveness of Subcutaneously Administered Leuprolide Acetate to Achieve Low Nadir Testosterone in Prostate Cancer Patients
  著者:: Pieczonka, Christopher M., 等
  出版事項: (2018)
• Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer
  著者:: Spitz, A, 等
  出版事項: (2012)
• Pharmacokinetic–Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats
  著者:: Lee, Dong-Seok, 等
  出版事項: (2018)
• Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer
  著者:: Lebret, Thiery, 等
  出版事項: (2015)
• Pharmacokinetic and pharmacodynamic comparison of subcutaneous intramuscular leuprolide acetate formulations in male subjects
  著者:: Daniel Saltzstein, 等
  出版事項: (2018-02-01)